President Trump’s newly passed One Big Beautiful Bill Act will, by most conventional estimates, add trillions to America’s national debt to pay for permanent tax cuts. Republicans insist the bill ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Former Senate HELP ranker Richard Burr has pulled in yet another new lobbying client from the pharmaceuticals world.

'Ozempic economy' explained as research suggests drug could save US taxpayers $173,000,000,000 a year The diabetes drug could help to reform the US economy ...

Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes.

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and eyes. Learn the signs and symptoms.

Ozempic-like drug significantly reduces frequency of chronic migraines in pilot study by Krystal Kasal, Phys.org edited by Gaby Clark, reviewed by Robert Egan Editors' notes ...

Ozempic for blood sugar control and Wegovy for weight loss both use different levels of semaglutide, a GLP-1 agonist. Victoza and Saxenda use another GLP-1 agonist, liraglutide. Tirzepatide — Eli ...

Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of technology used in the oral version of the blockbuster diabetes drug Ozempic.

Patients taking semaglutide, the active ingredient in Ozempic, were less likely to develop Alzheimer’s. Randomized clinical trials are needed to pin down the exact cause of this difference in risk.